报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2022-03-31 | 61.7% | 16.93% | 9.68% | 47/140 | 54.18% | 迪哲医药 | 97.73% | 行业排名> |
2021-12-31 | 56.25% | -4.36% | 3.3% | 63/140 | 54.86% | 百利天恒 | 97.99% | 行业排名> |
2021-09-30 | 54.45% | -17.14% | 0.63% | 66/140 | 47.21% | 百利天恒 | 98.92% | 行业排名> |
2021-06-30 | 54.11% | -19.23% | 2.56% | 69/140 | 47.14% | 迈威生物 | 98.93% | 行业排名> |
2021-03-31 | 52.76% | -21.7% | -10.29% | 68/140 | 54.18% | 迈威生物 | 99.59% | 行业排名> |
2020-12-31 | 58.81% | -8.83% | -10.51% | 59/140 | 56.2% | 迈威生物 | 99.8% | 行业排名> |
2020-09-30 | 65.72% | 1.9% | -1.91% | 38/140 | 56.96% | 迈威生物 | 99.46% | 行业排名> |
2020-06-30 | 67% | 4.26% | -0.58% | 36/140 | 55.29% | 迈威生物 | 99.75% | 行业排名> |
2020-03-31 | 67.39% | 8.02% | 4.46% | 30/140 | 56.34% | 迈威生物 | 99.67% | 行业排名> |
2019-12-31 | 64.51% | -6.3% | 0.02% | 45/140 | 56.31% | 迈威生物 | 99.44% | 行业排名> |
2019-09-30 | 64.5% | -31.65% | 0.37% | 38/140 | 56.35% | 迈威生物 | 98.57% | 行业排名> |
2019-06-30 | 64.26% | -29.6% | 3.01% | 42/140 | 56.51% | 首药控股 | 99.93% | 行业排名> |
2019-03-31 | 62.39% | -33.17% | -9.39% | 39/140 | 52.81% | 艾力斯 | 99.41% | 行业排名> |
2018-12-31 | 68.85% | 117.52% | -27.04% | 38/140 | 52.28% | 艾力斯 | 98.7% | 行业排名> |
2018-09-30 | 94.36% | -1.9% | 3.37% | 2/140 | 55.6% | 艾力斯 | 99.4% | 行业排名> |
2018-06-30 | 91.28% | -4.84% | -2.22% | 5/140 | 55.26% | 首药控股 | 99.94% | 行业排名> |
2018-03-31 | 93.36% | 5.31% | 194.95% | 3/140 | 55.96% | 泽璟制药 | 99.96% | 行业排名> |
2017-12-31 | 31.65% | 519.06% | -67.09% | 100/140 | 53.17% | 微芯生物 | 95.14% | 行业排名> |
2017-09-30 | 96.19% | 2208.13% | 0.27% | 1/140 | 50.64% | 多瑞医药 | 95.59% | 行业排名> |
2017-06-30 | 95.93% | 2762.38% | 8.21% | 1/140 | 49.23% | 微芯生物 | 95.81% | 行业排名> |
2017-03-31 | 88.65% | 2537.1% | 1633.82% | 4/140 | 48.09% | 微芯生物 | 96.09% | 行业排名> |
2016-12-31 | 5.11% | 44.6% | 22.69% | 113/140 | 48.69% | 微芯生物 | 96.11% | 行业排名> |
2016-09-30 | 4.17% | 2.87% | 24.35% | 81/140 | 45.95% | 微芯生物 | 95.5% | 行业排名> |
2016-06-30 | 3.35% | -10.51% | -0.31% | 90/140 | 46.7% | 微芯生物 | 96.27% | 行业排名> |
2016-03-31 | 3.36% | -2.96% | -4.93% | 81/140 | 43.41% | 贝达药业 | 95.47% | 行业排名> |
2015-12-31 | 3.54% | 12.68% | -12.72% | 105/140 | 46.05% | 贝达药业 | 95.51% | 行业排名> |
2015-09-30 | 4.05% | 39.87% | 8.18% | 80/140 | 43.95% | 贝达药业 | 95.54% | 行业排名> |
2015-06-30 | 3.74% | 21.74% | 8.1% | 84/140 | 44.63% | 贝达药业 | 95.74% | 行业排名> |
2015-03-31 | 3.46% | 8.14% | 10.39% | 75/140 | 42.18% | 退市金泰 | 96.19% | 行业排名> |
2014-12-31 | 3.14% | -94.72% | 8.35% | 102/140 | 43.29% | -- | -- | 行业排名> |
2014-09-30 | 2.9% | -94.8% | -5.84% | 69/140 | 41.28% | -- | -- | 行业排名> |
2014-06-30 | 3.08% | -94.85% | -3.97% | 72/140 | 40.54% | -- | -- | 行业排名> |
2014-03-31 | 3.2% | -90.62% | -94.25% | 71/140 | 39.37% | -- | -- | 行业排名> |